Search Results - "Carlo Lucioni"

Refine Results
  1. 1

    Value of health technologies, HTA and decisions by Carlo Lucioni, Claudio Jommi

    “…Value of health technologies, HTA and decisionsHTA is a multifaceted discipline, and several themes are key to an in-depth analysis of its current and future…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Valore delle tecnologie sanitarie, HTA, decisioni by Lucioni, Carlo, Jommi, Claudio

    “…Value of health technologies, HTA and decisions HTA is a multifaceted discipline, and several themes are key to an in-depth analysis of its current and future…”
    Get full text
    Journal Article
  7. 7

    Health care costs of comorbidities in patients with HIV infection in Italy. An estimate using a Delphi panel by Carlo Lucioni, Silvio Mazzi, Giuliano Bensi

    “…In HIV affected patients, co-morbidities (also termed opportunistic infections or AIDS-defining events) characterise the disease progression, resulting from…”
    Get full text
    Journal Article
  8. 8

    First drug utilization data related to an anticholinergic agent recently marketed in Italy by Carlo Lucioni, S. Mazzi, C. Cerra, S. Lottaroli

    “…A retrospective drug utilisation study was conducted, concerning a new bronchodilator (tiotropium, ATC code: R03BB04) in the first six months after its launch…”
    Get full text
    Journal Article
  9. 9

    Cost of an outbreak of hepatitis A in Puglia, Italy by Lucioni, C, Cipriani, V, Mazzi, S, Panunzio, M

    Published in PharmacoEconomics (01-02-1998)
    “…In total, 5889 cases of hepatitis A virus infection were reported during an outbreak in Puglia, a region of Southern Italy, in 1996. The primary cause of the…”
    Get full text
    Journal Article
  10. 10

    Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis by Gasparini, Roberto, Landa, Paolo, Amicizia, Daniela, Icardi, Giancarlo, Ricciardi, Walter, de Waure, Chiara, Tanfani, Elena, Bonanni, Paolo, Lucioni, Carlo, Testi, Angela, Panatto, Donatella

    Published in Human vaccines & immunotherapeutics (02-08-2016)
    “…The European Medicines Agency has approved a multicomponent serogroup B meningococcal vaccine (Bexsero®) for use in individuals of 2 months of age and older. A…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Letter to the Editor by Lucioni, Carlo, Mazzi, Silvio

    Published in Vaccine (10-03-2006)
    “…[...]the difference is not negligible and may have important implications for decision makers since, as the Authors remind, the "commonly accepted benchmarks…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Economic Evaluation of Levosimendan Versus Dobutamine for the Treatment of Acute Heart Failure in Italy by Lucioni, Carlo, D’Ambrosi, Alessandra, Mazzi, Silvio, Pollesello, Piero, Apajasalo, Marjo, Fedele, Francesco

    Published in Advances in therapy (01-12-2012)
    “…Introduction Inodilators are the first-choice class of drugs for the treatment of acute heart failure (AHF). Levosimendan is a relatively recent inodilatory…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cost of Cystic Fibrosis: Analysis of Treatment Costs in a Specialized Center in Northern Italy by Colombo, Carla, Daccò, Valeria, Alicandro, Gianfranco, Loi, Silvana, Mazzi, Silvio, Lucioni, Carlo, Ravasio, Roberto

    Published in Advances in therapy (01-02-2013)
    “…Introduction Advances in cystic fibrosis (CF) therapy have resulted in improved survival and increasing treatment burden and costs. The economic impact of…”
    Get full text
    Journal Article